⌘K
Eikon Therapeutics
Healthcare & Life Sciences
Recent Finacing
Series D
Recent Raise
$350.7M
Eikon Therapeutics develops new medicines using advanced technologies like single-molecule tracking and high-performance computing to accelerate drug discovery and development.
Focus Areas
Biotechnology
Drug Discovery
Clinical Trials
Advanced Melanoma
Single-Molecule Tracking
High-Performance Computing
Investors
